Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Central Line Complication”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT03682068
What this trial is testing

Study of Durvalumab Given With Chemotherapy, Durvalumab in Combination With Tremelimumab Given With Chemotherapy, or Chemotherapy in Patients With Unresectable Urothelial Cancer

Who this might be right for
Unresectable Locally Advanced Urothelial CancerMetastatic Urothelial Cancer
AstraZeneca 1,246
Large-scale testing (Phase 3)Looking for participantsNCT06952504
What this trial is testing

Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)

Who this might be right for
Endometrial Cancer
Merck Sharp & Dohme LLC 1,123
Not applicableLooking for participantsNCT07183592
What this trial is testing

Impact of Infusion Line Change Frequency on Infectious Complications Related to Central Venous Catheters in the ICU - A Randomized Controlled Trial

Who this might be right for
Intensive Care (ICU)Central Venous Catheter Related InfectionsCritical Care Nursing+2 more
University Hospital, Angers 2,830
Testing effectiveness (Phase 2)Study completedNCT01379534
What this trial is testing

A Phase II Study to Evaluate the Efficacy of TKI258 for the Treatment of Patients With FGFR2 Mutated or Wild-type Advanced and/or Metastatic Endometrial Cancer

Who this might be right for
Solid Tumors and Advanced Endometrial CancerEndometrial CancerSecond-line Treatment+1 more
Novartis Pharmaceuticals 53
Testing effectiveness (Phase 2)Study completedNCT04188847
What this trial is testing

First-line Chemotherapy for Recurrent Cervical Cancer

Who this might be right for
Recurrent Cervical CarcinomaPersistent Advanced Cervical CarcinomaChemotherapy+3 more
Lei Li 37
Not applicableEnded earlyNCT05228132
What this trial is testing

The Pristine Post-Market Study

Who this might be right for
Kidney Failure, ChronicHemodialysis ComplicationHemodialysis Catheter Infection+3 more
C. R. Bard 142
Not applicableUnknownNCT01603914
What this trial is testing

Central Venous Catheter Replacement Strategies in Adult Patients With Major Burn Injury

Who this might be right for
Catheter-related Bloodstream InfectionComplication of Catheter
Hospital Universitario Getafe 1,120
Large-scale testing (Phase 3)Study completedNCT00102375
What this trial is testing

Paclitaxel, Carboplatin, and Topotecan in Patients With Ovarian Cancer

Who this might be right for
Ovarian Cancer
AGO Study Group 900
Post-approval studies (Phase 4)Not Yet RecruitingNCT07652515
What this trial is testing

Evaluate the Safety of Dostarlimab in Adult Participants in India With Primary Advanced or Recurrent Endometrial Cancer

Who this might be right for
Neoplasms, Endometrial
GlaxoSmithKline 100
Not applicableUnknownNCT02932800
What this trial is testing

Fixing the Short Stay Central Venous Catheter: Comparison of Two Techniques

Who this might be right for
Suture, Complication
Universidade do Vale do Sapucai 62
Not applicableStudy completedNCT05911451
What this trial is testing

Optimizing Access Surgery In Senior Hemodialysis Patients

Who this might be right for
Vascular Access ComplicationHemodialysis Access FailureDialysis Access Malfunction+3 more
Maastricht University Medical Center 166
Not applicableStudy completedNCT04674371
What this trial is testing

German Point Prevalence Study on CVC

Who this might be right for
Data Collection
Wolfram Schummer, MD, PhD 537
Not applicableWithdrawnNCT06884176
What this trial is testing

CVCs Versus Midline Catheters

Who this might be right for
Central Venous CatheterMidline CatheterComplication of Catheter
Albert Einstein College of Medicine
Not applicableStudy completedNCT05734911
What this trial is testing

Effectiveness and Safety of Niraparib as First-line Maintenance Therapy for Ovarian Cancer: a Real-world Study

Who this might be right for
Ovarian Neoplasms
Zhongda Hospital 199
Testing effectiveness (Phase 2)UnknownNCT05585281
What this trial is testing

Fluzoparib Combined With QL1101 Maintenance Treatment in Patients With Advanced Ovarian Cancer Following Response on Front-Line Platinum-Based Chemotherapy

Who this might be right for
Ovarian Cancer
Yongpeng Wang 25
Not applicableStudy completedNCT01988766
What this trial is testing

Risk of Central Venous Stenosis in Patients With Chronic Renal Failure After IJ Line Placement

Who this might be right for
Thrombosis
University of Chicago 1,424
Not applicableUnknownNCT06373575
What this trial is testing

IVC and Lung Ultrasound B-lines Guided Decongestion in Critically Ill ESKD Patients With Heart Failure

Who this might be right for
End-stage Renal Disease
The First Affiliated Hospital with Nanjing Medical University 40
Testing effectiveness (Phase 2)Study completedNCT01397877
What this trial is testing

GINECO-EN102b - BKM120 as Monotherapy in the Treatment of Initial or Recurrent Metastatic Endometrial Cancer

Who this might be right for
Endometrial Cancer
ARCAGY/ GINECO GROUP 24
Testing effectiveness (Phase 2)UnknownNCT05124431
What this trial is testing

Anlotinib Plus Everolimus as First-line Treatment for Advanced Non Clear Cell Renal Cell Carcinoma

Who this might be right for
Renal Cell Carcinoma
Fudan University 30
Testing effectiveness (Phase 2)Looking for participantsNCT06690697
What this trial is testing

Combination of Toripalimab and JS004 Therapy for ccRCC

Who this might be right for
Clear Cell Renal Cell Carcinoma
Fudan University 80
Next Page